|
||
Title: Attention telefoon call from Glaxo Post by J.ten_Dam on Nov 6th, 2003, 11:10am I have plased this massage on the medical board as well. Attention telefoon call from Glaxo « on: Today at 9:25am » Quote Modify Remove -------------------------------------------------------------------------------- as I mentiond on the 5 under Glaxo and 1/2 imitrax auro injector « on: Nov 5th, 2003, 7:04am » I have emaild them yesterday and today I was phoned by a gentilman from the research department. http://www.gsk.nl/watwedoen/klinischonderzoek/ does research on ilness and medication. [font=Verdana][/font] He informd me that a survay had been done a while ago and the result was that not meny people had benifit in lower dosage!!!!!!!!!!!. Now pease let us show them that it is not so. Annyone using the Imitrax tip Please sen these people an e-mail stating wether you are cronik or episodik. Why you resort to using lower dosagees and how long you have been doing this and also mention whether it is as effective as the normal dosage. The more E-mails they get the sooner they will restart the tryals which were planed anywhay because they have been getting feed back from neurologists that mention that their patients are using lover dosages. |
||
Title: Re: Attention telefoon call from Glaxo Post by Mark C on Nov 6th, 2003, 11:28am I am all for lower doses for several reasons. One being I should be able to treat more HA in a 24 hour period without exceeding the recommeded dosage. Another is to make what little Imitrex I get last a little longer. However.....I do not believe Glaxo would lower the price of a lesser dose for one thing, and I think that is one of the reasons for a smaller dose..less money would be nice. Having been researching Imitrex Injection more in-depth just recently the 6mg dose came after studys shown that was the ideal dose to treat migrains. Even at doses of 12mg and even 18 mg no siginificant decrease in pain occured....with migrains. From what I have read on this board many achieve relief with as little as 2mg dose. In this kind of treatment less is more to me. A small dose applicator from Glaxo would not surprise me....a decrease in price would. FYI...I had a Neurologist appointment today and since I am lucky enough to have both the Auto-Injector and the single use vials I asked about halfing the dose using the vials. The reply was since these are single use vials are indeed single use, Imitrex injection has no preservative and she is worried about not only the safety of the Imitrex but also the sterilty of re-using a single use vial. I still intend on trying a half dose, carefully....with a new syringe each time. PFDAN's Mark |
||
Title: Re: Attention telefoon call from Glaxo Post by J.ten_Dam on Nov 6th, 2003, 11:52am Hi mark why not mention this in an e-mail to glaxco. Who knows what they will say. By the way in holland the survay was done with clusterheads as wel as migrainers |
||
Title: Re: Attention telefoon call from Glaxo Post by Mark C on Nov 6th, 2003, 12:00pm J-Ten, I think I will, what do we have to lose but some pain? PFDAN's Mark |
||
Title: Re: Attention telefoon call from Glaxo Post by Jayne on Nov 6th, 2003, 12:56pm This worries me ...for people who DON"T have health insurance. I am sure if Glaxo made lesser dosages..the price would not lower that much. At least with the tip we can get more for our $ if you know what I mean. Then you would have problems with doctors understanding prescribing the lower dosage...how many we actually need. I am happy to use the tip and save some money on each headache. I think this lower dose pack from glaxo has potential of coming back to bite us in the arse eventually. Don't forget they are a BUSINESS and want to make money, they don't really give a rats arse about the individual and how much pain they go through and how much they have to pay through the nose to lessen that pain. *stepping off my soap box*:-) |
||
Title: Re: Attention telefoon call from Glaxo Post by vig on Nov 6th, 2003, 2:16pm What did we get for receiving a $2,500 'donation' from Glaxo? How long does it take for Glaxo to make that $2,500 back from us on CH.com at $70 a pop? 5 seconds? 10? Maybe we need to consider that Glaxo is not an ally in our cause. How many people here have I read about that are in SERIOUS financial trouble from buying Imitrex? I think we should send the $2,500 back to them. Am I the only one? Paul |
||
Title: Re: Attention telefoon call from Glaxo Post by thomas on Nov 6th, 2003, 2:21pm No, you are not alone vig. |
||
Title: Re: Attention telefoon call from Glaxo Post by Mark C on Nov 6th, 2003, 2:36pm Well lets not be TOO hasty.....my Neruro gave me about $2000 (!) in samples this morning and because of my insurance (which I pay for) I am able to get $1280 of Imitrex injection for an $80.00 co-pay. Don't get me wrong...I hate drug companies almost as much as Attorneys....but they do have the Trex! I am changing my tune as we speak as to what really works and what side effects are worth the trouble. Oh yeah....Glaxo is gonna get rich anyway so you may as well buy some stock! ;;D Onward through the fog! Mark |
||
Title: Re: Attention telefoon call from Glaxo Post by vig on Nov 6th, 2003, 2:47pm A good crack dealer gives out plenty o' crack before the cha-ching begins... |
||
Title: Re: Attention telefoon call from Glaxo Post by thomas on Nov 6th, 2003, 3:14pm [smiley=smug.gif]I need the cha-ching to get my bling-bling. |
||
Title: Re: Attention telefoon call from Glaxo Post by Mark C on Nov 6th, 2003, 3:29pm 8) Seriously though, I don't believe for a minute Glaxo exists to better the condition of Humanity.....however....I still get a bunch of free meds every visit to the Doc. If I didn't I would run out, even with letters from my Doc and such. Point taken vig :) Later yall, Mark |
||
Title: Re: Attention telefoon call from Glaxo Post by floridian on Nov 6th, 2003, 3:40pm I see no problem in accepting money from Big Pharmacy as long it doesn't require any compromise (and I don't see any happening). Maybe alternative funding could be sought from someone like gazillionare phillanthropist George Soros. He was a big backer of the medical mary jane initiatives. Medical mushrooms make sense, but this is such a 'rare' disease, and US drug policy is dominated by emotion and hysteria, not reason. |
||
Title: Re: Attention telefoon call from Glaxo Post by Charlie on Nov 6th, 2003, 4:59pm Since these drug company If only we lived in Oz. >:( Charlie |
||
Title: Re: Attention telefoon call from Glaxo Post by vig on Nov 6th, 2003, 5:07pm One of the biggest problems here (as I see it) is the price of medicine, and Imitrex is the big one. They refuse to lower the price. They refuse to make Imitrex available in the doses we need. They have done nothing in reality to help our cause except pretend to be a sponsor and by accepting the money, we tacitly agreed to their claim. They gave us the $2,500 to shut us up. |
||
Title: Re: Attention telefoon call from Glaxo Post by Prense on Nov 6th, 2003, 6:29pm on 11/06/03 at 17:07:03, vig wrote:
The biggest problem is the monopoly... |
||
Title: Both Right! Post by floridian on Nov 6th, 2003, 7:21pm Only a monopoly allows the price to be set so high. The patent/copyright IP system keeps getting adjusted to extend the monopoly. People believe that modern patent medicines are more effective than the old snake oil cure, but I wonder - is snake oil anything like fish oil or flax oil?? |
||
Title: Re: Attention telefoon call from Glaxo Post by Mark C on Nov 6th, 2003, 8:00pm The table below sets out patent expiry dates for the active ingredients in significant GlaxoSmithKline products. Therapeutic area Product Active ingredient(s) Patent expiry dates for active ingredient(s) in major countries CNS disorders Seroxat/Paxil paroxetine During or after 2006 Wellbutrin bupropion Basic compound patents have expired. Formulation patents will expire during or after 2013 Imigran/Imitrex sumatriptan During or after 2003 (USA 2006) Naramig/Amerge naratriptan During or after 2010 Lamictal lamotrigine During or after 2005 Requip ropinirole During or after 2007 Zyban bupropion Basic compound patents have expired. Formulation patents will expire during or after 2013 There were quite a few more, Look here. (http://www.gsk.com/financial/reports/ar/report/descrip_of_bus/intell_property/intell_prop.html) For some reason I am not sure this is going to help us much. It looks like Glaxo is losing quite a few lucrative patents in the next few years.....hard on their bottom line. I reckon they must keep discovering (inventing) new drugs to maintain the monoply. It's all about the Benjamin. PFDAN's Mark |
||
Title: Re: Attention telefoon call from Glaxo Post by floridian on Nov 6th, 2003, 8:56pm Lately the patent medicine companies have gotten a couple years of extension by challenging anyone who wants to make a generic in court. The patent holders ultimately lose, but keep things tied up for an extra billion or two. Generic companies are being bought up and suddenly decide to stick with aspirin. Other generic companies have negotiated contracts so that they get paid more not to manufacture a newly expired patent generic than they could make by manufacturing that med - after all, they don't need production facilities to not produce something, so its pure profit. Other than that, everybody wins. |
||
Title: Re: Attention telefoon call from Glaxo Post by Patrick_A on Nov 7th, 2003, 12:43am Its kind of like a 2 liter bottle of Coca-Cola. The actual soda cost about 2 cents to make, and the plastic bottle that it comes in is another 5 cents. Its the marketing that cost the large percentage. Did you know that Drug companies have a slush fund for drugs gone bad? Lets say that Imitrex 20 years down the road is found to have created heart problems and some Tort lawyers decide to sue Glaxco. Glaxco of course will fight like hell to keep from having to pay, but if they do have to pay, it just comes from the slush fund. Why do ya reckon Imitrex cost $70.00 a pop! Just something to think about! Patrick |
||
Clusterheadaches.com Message Board » Powered by YaBB 1 Gold - SP 1.3.1! YaBB © 2000-2003. All Rights Reserved. |